Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion

September 2019, Volume 205, Pages 200–201
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Re: Chan et al: Disorganization of Retinal Inner Layers and Ellipsoid Zone Disruption Predict Visual Outcomes in Central Retinal Vein Occlusion. (Ophthalmol Retina. 2019;3:83-92)

September 2019, Volume 3, Issue 9, Page e9
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Re: Bailey et al: Intralesional macular atrophy in anti-vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial (Ophthalmology. 2019;126:75–86)

September 2019, Volume 126, Issue 9, Pages e71–e72
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Multiple Effects Of Intravitreal Aflibercept On Microvascular Regression In Eyes With Diabetic Macular Edema

August, 2019, Volume 09, Issue 08, pp.29071-29072
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Comment on "The thickness and volume of the choroid, outer retinal layers and retinal pigment epithelium layer changes in patients with diabetic retinopathy"

August 2019, Volume 12,Issue 08, p.1366-1368
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Patient Characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage

July 2019, Volume 09, Issue 07, pp.28800-28801
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Loss of peak vision in retinal vein occlusion patients treated for macular edema

July 2019, Volume 09, Issue 07, pp.28783-28784
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser

June 2019, Volume 11, Issue 06, pp.4439-4440
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

A two-year study of diffused retinal pigment epitheliopathy treated with half-dose photodynamic therapy guided by simultaneous angiography and optical coherence tomography

June 2019, Volume 11, Issue 06, pp.4480-4481
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Randomized Trial Of Wide-Field Guided Prp For Diabetic Macular Oedema Treated With Ranibizumab

June 2019, Volume 11, Issue 06, pp.4876-4877
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Ischemic retinal vein occlusion: Characterizing the more severe spectrum of retinal vein occlusion

May–June 2019, Volume 64, Issue 3, Pages 440–441
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Predictive Factors of Response to Mineralocorticoid Receptor Antagonist in Nonresolving Central Serous Chorioretinopathy

May 2019, Volume 201, Pages 87–88
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Management of the open angle glaucoma in patients with central/hemicentral retinal vein occlusions

March 2019, Volume 12, Issue 3, pp.436-441
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics

February 2019, Volume 11, Issue 02, pp.1614-1615
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 Phoenix Study

February 2019, Volume 198, Pages 262–263
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial

January 2019, Volume 126, Issue 1, Pages e10–e11
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema

January 2019, Volume 257, Issue 1, pp. 241–242
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Re: Berry et al: Association of Disorganization of Retinal Inner Layers with Ischemic Index and Visual Acuity in Central Retinal Vein Occlusion

January 2019, Volume 3, Issue 1, page e1
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Comment on “Intravitreal dexamethasone implants for diabetic macular edema”

December 2018, Volume 11, Issue 12, p. 2029-2032
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting

December 2018, Volume 196, p. 208–209
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”

November 2018, Volume 11, Issue 11, p. 1884-1886
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization

November 2018, Volume 195, p. 245–246
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the united states

October 2018, Volume 10, Issue 10, pp.74665-74666
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania

Bun venit!

Cu entuziasm și profesionalism, Dr. Dan CĂLUGĂRU a format o echipă bine pregătită, care având la dispoziție tehnică medicală performantă, ajută la rezolvarea problemelor oftalmologice, punând întotdeauna accent pe confortul și siguranța pacienților, oferind servicii oftamologice complete la standarde înalte de calitate, atât prin experiența profesională cât și ca nivel al dotării cu aparatură. Echipa beneficiază de suportul și experiența Prof. Univ. Dr. Mihai Călugăru.

În clinica noastră se tratează peste 3000 de pacienți anual, număr în permanentă creștere, având în vedere progresul științific și tehnic de care echipa Dr. Călugăru este mereu preocupată.

Echipamentele noaste sunt furnizate de către producători consacrați în domeniu: Alcon (S.U.A), Bausch & Lomb (SUA), Blanco (Germania), Brumaba (Germania), Carl Zeiss Meditec (Germania), Spacelabs (S.U.A), Getinge (Suedia), Tomey (Japonia), Melag (Germania), Nidek (Japonia), Briot (Belgia).

Pentru operațiile de reducere a dioptriilor cu laser excimer (Lasek, Prk) nu este nevoie de analize. Pentru toate celelalte intervenții chirurgicale analizele sunt obligatorii.

Analizele necesare pentru operație:

  • Hemoleucograma
  • Coagulograma
  • Glicemie
  • Uree
  • VSH
  • AST
  • ALT
  • Bilirubina totală
  • HVB
  • HVC
  • HIV
  • Consult cardiologic
  • EKG

Pentru a reuși vindecarea unui număr cât mai mare de pacienți echipa Dr. Călugăru colaborează cu mai mulți medici specializați în oftalmologie, opticieni și optometriști, cât și cu medicii de familie din zonele învecinate.